HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Miles Prince Selected Research

Urinary Tract Infections (Urinary Tract Infection)

1/2022Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study.
12/2019Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H Miles Prince Research Topics

Disease

50Neoplasms (Cancer)
01/2023 - 05/2004
35Multiple Myeloma
02/2024 - 07/2003
21Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2022 - 10/2007
17Lymphoma (Lymphomas)
02/2024 - 02/2004
16Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
02/2024 - 04/2011
13Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2020 - 11/2009
12Mycosis Fungoides
11/2022 - 04/2010
11Infections
01/2023 - 11/2004
10T-Cell Lymphoma (Lymphoma, T Cell)
05/2021 - 11/2009
7Disease Progression
01/2019 - 07/2003
5Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2020 - 06/2006
5Hodgkin Disease (Hodgkin's Disease)
01/2019 - 01/2006
4Sezary Syndrome (Sezary Erythroderma)
11/2023 - 01/2017
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2023 - 08/2006
4Sepsis (Septicemia)
01/2022 - 10/2011
4Peripheral Nervous System Diseases (PNS Diseases)
12/2021 - 09/2006
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2021 - 02/2004
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
10/2020 - 05/2004
4Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 06/2006
4Leukemia
05/2017 - 10/2007
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2013 - 04/2005
4Hematologic Neoplasms (Hematological Malignancy)
10/2012 - 12/2005
3Thrombocytopenia (Thrombopenia)
01/2022 - 11/2007
3Pneumonia (Pneumonitis)
01/2022 - 10/2011
3Neutropenia
01/2022 - 11/2007
3Lymphomatoid Papulosis
06/2015 - 05/2009
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2013 - 08/2011
3Febrile Neutropenia
02/2013 - 08/2004
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2023 - 12/2019
2Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 12/2019
2Primary Cutaneous Anaplastic Large Cell Lymphoma
12/2021 - 01/2017
2Immunoglobulin Light-chain Amyloidosis
10/2021 - 06/2012
2Cytopenia
11/2019 - 09/2008
2Crohn Disease (Crohn's Disease)
05/2017 - 02/2011
2Lymphadenopathy
01/2016 - 11/2015
2Castleman Disease (Castleman's Disease)
01/2016 - 03/2010
2Stomatitis
08/2014 - 07/2005
2Mucositis
08/2014 - 07/2005
2Central Nervous System Diseases (CNS Diseases)
12/2012 - 10/2009
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2010 - 09/2005
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2010 - 03/2007
2Melanoma (Melanoma, Malignant)
05/2009 - 10/2007
1Frailty
01/2023
1Latent Infection
01/2023

Drug/Important Bio-Agent (IBA)

19Histone Deacetylase InhibitorsIBA
10/2020 - 05/2007
16romidepsin (FK228)FDA Link
12/2017 - 11/2009
15Dexamethasone (Maxidex)FDA LinkGeneric
02/2024 - 06/2005
13Thalidomide (Thalomid)FDA Link
01/2019 - 07/2003
12Rituximab (Mabthera)FDA Link
05/2017 - 02/2004
9Lenalidomide (CC 5013)FDA Link
01/2023 - 10/2005
9Bortezomib (Velcade)FDA Link
01/2019 - 08/2006
9fludarabineIBA
05/2016 - 05/2004
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 05/2004
8PanobinostatIBA
05/2014 - 07/2008
6Methotrexate (Mexate)FDA LinkGeneric
12/2021 - 10/2006
5Brentuximab VedotinIBA
01/2023 - 01/2017
5CytokinesIBA
01/2016 - 12/2005
5Melphalan (Alkeran)FDA LinkGeneric
08/2014 - 07/2005
5denileukin diftitox (Ontak)FDA Link
08/2013 - 05/2004
4Monoclonal AntibodiesIBA
02/2024 - 02/2004
4pomalidomideIBA
02/2024 - 12/2019
4isatuximabIBA
02/2024 - 12/2019
4InterferonsIBA
01/2023 - 07/2003
4Chimeric Antigen ReceptorsIBA
01/2023 - 11/2013
4Prednisolone (Predate)FDA LinkGeneric
01/2021 - 04/2009
4AntigensIBA
05/2017 - 12/2005
4Antineoplastic Agents (Antineoplastics)IBA
11/2009 - 10/2007
3Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 06/2005
3Biomarkers (Surrogate Marker)IBA
08/2020 - 01/2006
3Interleukin-2 (IL2)IBA
05/2017 - 05/2004
3Alemtuzumab (Campath)FDA Link
01/2017 - 02/2003
3AnthracyclinesIBA
08/2014 - 07/2006
3Histones (Histone)IBA
09/2013 - 06/2009
3Proteins (Proteins, Gene)FDA Link
08/2013 - 07/2005
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2008 - 07/2006
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 12/2018
2Proteasome InhibitorsIBA
01/2022 - 12/2019
2Bexarotene (LGD1069)FDA Link
12/2021 - 01/2013
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 09/2008
2daratumumabIBA
01/2021 - 12/2018
2EpitopesIBA
05/2017 - 10/2010
2Capsules (Microcapsules)IBA
06/2016 - 01/2014
2Anti-Bacterial Agents (Antibiotics)IBA
08/2014 - 11/2012
2Azacitidine (5 Azacytidine)FDA Link
09/2013 - 08/2011
2DepsipeptidesIBA
06/2011 - 11/2009
2PerforinIBA
04/2011 - 01/2008
2Mitoxantrone (Novantrone)FDA LinkGeneric
11/2006 - 11/2004
1PlasticsIBA
02/2024
1elotuzumabIBA
01/2023

Therapy/Procedure

55Therapeutics
11/2023 - 11/2004
21Drug Therapy (Chemotherapy)
01/2019 - 08/2002
15Breast Implants (Breast Implant)
02/2024 - 04/2011
15Stem Cell Transplantation
01/2021 - 05/2005
7Radiotherapy
01/2023 - 07/2009
5Salvage Therapy
01/2015 - 09/2005
4Immunotherapy
05/2017 - 12/2006
3Photopheresis
01/2022 - 10/2008
2Ligation
05/2015 - 12/2005
2Aftercare (After-Treatment)
01/2015 - 08/2006
2Combination Drug Therapy (Combination Chemotherapy)
08/2006 - 11/2004